Physician’s Briefing Weekly Coronavirus Roundup
Rates of Acute Allergic Reactions to COVID-19 Vaccines Extremely Low
Most recipients with anaphylaxis had allergy histories, with 31 percent having prior anaphylaxis
Tocilizumab Use Not Supported for Moderate-to-Severe COVID-19
Progression of COVID-19 up to day 14 did not differ with addition of tocilizumab to standard care in Phase 3 trial conducted in India
One in Five Health Care Workers Reports Mental Health Conditions
Review shows high prevalence of depression, anxiety, and PTSD during the COVID-19 pandemic
Alcohol Withdrawal Rates Up in Hospitalized Patients During Pandemic
Rates for hospitalized patients consistently higher compared with 2019
Risk for Severe Outcomes in COVID-19 Increases With Increasing BMI
Risks for hospitalization, intensive care unit admission, and death increased sharply with higher BMIs
Listeria-Linked Soft Cheese Recall Expands to More States: FDA
Recall first announced Feb. 19, but on Tuesday, the FDA said the cheeses had been distributed to at least 26 states
Researchers Differentiate MIS-C From Severe COVID-19 in Children
Severe cardiovascular or mucocutaneous involvement, more extreme inflammation are among distinguishing features of MIS-C
U.K., U.S. COVID-19 Symptom Checkers May Delay Health Contact
Symptom checkers for U.K., U.S. consistently failed to identify severe COVID-19, bacterial pneumonia, sepsis
Suicide Decedents in Child Welfare System Had Used Health Services
Young suicide decedents more likely to have accessed mental health services, physical health services; visited ED
